New Platinum Agents
- 1 August 1994
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 5 (2) , 85-95
- https://doi.org/10.2165/00002512-199405020-00002
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.1994
- Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer.Journal of Clinical Oncology, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- PRECLINICAL ANTITUMOR EVALUATION OF BIS-ACETATO-AMMINE-DICHLORO-CYCLOHEXYLAMINE PLATINUM(IV) - AN ORALLY ACTIVE PLATINUM DRUG1993
- Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsBritish Journal of Cancer, 1993
- Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.Journal of Clinical Oncology, 1992
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesBritish Journal of Cancer, 1989
- Charles F. Kettring prize. Fundamental studies with cisplatinCancer, 1985